Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Citius Pharma

Citius Pharma
2007 FOUNDED
PUBLIC STATUS
1-10 EMPLOYEES
CTXR STOCK SYMBOL
2 INVESTMENTS
$1.08 SHARE PRICE (As of Tuesday Closing)
Description

Citius Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the development and commercialization of anti-infective products, adjunctive cancer care, and unique prescription products. Citius is currently advancing two proprietary product candidates, Mino-Lok product and a Hydrocortisone-Lidocaine formulation. Mino-Lok product is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections. The company's Hydrocortisone-Lidocaine provides anti-inflammatory and anesthetic relief to patients suffering from Grade I and II hemorrhoids. The company is primarily operating within the critical care and cancer care market segments.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 11 Commerce Drive
  • 1st Floor
  • Cranford, NJ 07016
  • United States

+1 (908) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Citius Pharma’s full profile, request a free trial.

Citius Pharma Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.86 - $2.52 $23.8M $1.11 -$0.79 90.7K 22.1M

Citius Pharma Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
30-Sep-2018
FY 2017
30-Sep-2017
FY 2016
30-Sep-2016
Enterprise Value 18,608 25,111 31,235 44,561
Revenue 0 0 0 0
EBITDA (14,783) (12,519) (9,532) (8,286)
Net Income (14,759) (12,537) (10,385) (8,296)
Total Assets 25,545 31,051 24,417 21,950
Total Debt 173 173 173 673
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Citius Pharma Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Citius Pharma‘s full profile, request access.

Request full access to PitchBook

Citius Pharma Competitors (46)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Recro Pharma Corporation Malvern, PA 000 00000 000000000 00000
000 000000 Private Equity-Backed Farmville, NC 000.00 000000000 000.00
00000 Corporate Backed or Acquired Mumbai, India 00000 00000000
000 00000 Corporation Indianapolis, IN 00000 0000
000000 Venture Capital-Backed San Francisco, CA 0 0000 000000000000 0000
To view this company’s complete list of competitors, request access »

Citius Pharma Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000-00000 0000 04-Apr-2016 000000000000000000 Biotechnology 0000000 00000
Trail One 12-Sep-2014 Merger/Acquisition 00.000 Other Consumer Products and Services
To view this company’s complete investment and acquisition history, request access »

Citius Pharma Executive Team (8)

Name Title Board
Seat
Contact
Info
Myron Holubiak Chief Executive Officer & Board Member
Jaime Bartushak Chief Financial Officer & Chief Accounting Officer
Gary Talarico Executive Vice President, Operations
Andrew Scott Vice President, Corporate Development
Leonard Mazur Chairman & Board Member

3 Former Executives

You’re viewing 5 of 8 executives. Get the full list »

Citius Pharma Board Members (8)

Name Representing Role Since Contact
Info
Carol Webb Citius Pharma Board Member 000 0000
Eugene Holuka MD Citius Pharma Board Member 000 0000
Howard Safir Citius Pharma Board Member 000 0000
Leonard Mazur Self Chairman & Board Member 000 0000
Myron Holubiak Citius Pharma Chief Executive Officer & Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 8 board members. Get the full list »